UK markets open in 5 hours 13 minutes
  • NIKKEI 225

    28,739.07
    -12.55 (-0.04%)
     
  • HANG SENG

    23,960.37
    -120.15 (-0.50%)
     
  • CRUDE OIL

    71.86
    +3.71 (+5.44%)
     
  • GOLD FUTURES

    1,795.40
    +7.30 (+0.41%)
     
  • DOW

    34,899.34
    -905.06 (-2.53%)
     
  • BTC-GBP

    43,097.94
    +2,488.05 (+6.13%)
     
  • CMC Crypto 200

    1,433.96
    -21.45 (-1.47%)
     
  • ^IXIC

    15,491.66
    -353.54 (-2.23%)
     
  • ^FTAS

    4,020.38
    -146.90 (-3.53%)
     

Drug Discovery Informatics Market Report 2021-2031

·8-min read

Forecasts by Type (Drug Development, Drug Discovery), by Phase (Preclinical Testing, Clinical Trials, Other), by End-user (Pharmaceutical, Biotechnology, Contract Research Organisations, Research Institutes, Other), by Function (Target Data, Sequencing & Target Data Analysis, Docking, Molecular Modelling, High Throughput Screening (HTS), Other), by Technique (Computer-Assisted Synthesis Design (CASD), Structure Representation, Chemmetrics, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios

New York, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Drug Discovery Informatics Market Report 2021-2031" - https://www.reportlinker.com/p06179170/?utm_source=GNW

The Drug Discovery Informatics Market Report 2021-2031: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Applying High-Performance Computing in Drug Discovery and Molecular Simulation

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government. This technique has resulted in a number of novel drug design algorithms and new software and databases. HPC is primarily applied to the discovery and molecular modelling of medication by the Chinese Academy of Sciences, including virtual drug screening, molecular simulation dynamics and protein folding.

Growth in Demand for Novel Drug Moieties

The therapeutic moieties cannot as such be administered, hence, for patient compliance, dose precision and consistency, bioavailability, aesthetics, and reduced adverse effects, they are changed to different dosage forms. Excipients are the basic needs for these changes, so that formulators can achieve their goals. Short excipients can be described as ‘the components of a formula other than the active component.’ As compounds grow increasingly difficult to create, the supply, production and development of these compounds must be supplied with novel excipients. The conventional excipients have been replaced with advanced chemicals that serve multifunctional roles in current pharmaceutical dosage forms such as improved stability and bioavailability, patient acceptance and technical performance to make manufacturing easier.

What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the drug discovery informatics market evolving?
• What is driving and restraining the drug discovery informatics market?
• How will each drug discovery informatics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2031?
• How will the market shares for each drug discovery informatics submarket develop from 2021 to 2031?
• What will be the main driver for the overall market from 2021 to 2031?
• Will leading drug discovery informatics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2031 and which geographical region will lead the market in 2031?
• Who are the leading players and what are their prospects over the forecast period?
• What are the drug discovery informatics projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2031?What are the implication of drug discovery informatics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the drug discovery informatics market?
• Where is the drug discovery informatics market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?

You need to discover how this will impact the drug discovery informatics market today, and over the next 10 years:
• Our 519-page report provides 341 tables and 323 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors

This report tells you TODAY how the drug discovery informatics market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising drug discovery informatics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.

Global Drug Discovery Informatics Market (COVID Impact Analysis) by Type
• Drug Development
• Drug Discovery

Global Drug Discovery Informatics Market (COVID Impact Analysis) by Phase
• Preclinical Testing
• Clinical Trials Phase
• Other Phase

Global Drug Discovery Informatics Market (COVID Impact Analysis) by End-User
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations
• Research Institutes
• Other End-User

Global Drug Discovery Informatics Market (COVID Impact Analysis) by Function
• Target Data
• Sequencing & Target Data Analysis
• Docking
• Molecular Modelling
• High Throughput Screening (HTS)
• Other Function

Global Drug Discovery Informatics Market (COVID Impact Analysis) by Technique
• Computer-Assisted Synthesis Design (CASD)
• Structure Representation
• Chemmetrics
• Other Technique

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 15 leading national markets:
• North America Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• U.S. Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Canada Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Mexico Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Europe Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• Germany Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Spain Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• United Kingdom Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• France Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Italy Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Europe Market Forecast & COVID Impact Analysis
• Asia Pacific Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• China Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Japan Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• India Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Australia Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• South Korea Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Asia Pacific Market Forecast & COVID Impact Analysis
• LAMEA Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• Brazil Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Turkey Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Saudi Arabia Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• South Africa Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• UAE Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Latin America, Middle East and Africa

The report also includes profiles and for some of the leading companies in the Drug Discovery Informatics Market, 2021 to 2031, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Jubilant Life Sciences
• Charles River Laboratories International
• International Business Machines Corporation
• Clarivate Analytics
• Accenture
• Cognizant Technology Solutions Corporation
• Thermo Fisher Scientific
• Infosys Limited
• GVK Biosciences
• IO Informatics
• OpenEye Scientific Software Inc.
• Dassault Systèmes SE
• Collaborative Drug Discovery
• Schrödinger, Inc
• PerkinElmer Inc

Overall world revenue for Drug Discovery Informatics Market, 2021 to 2031 in terms of value the market will surpass US$xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Drug Discovery Informatics Market, 2021 to 2031 Market report helps you?

In summary, our 519-page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Drug Discovery Informatics Market, 2021 to 2031 Market, with forecasts for type, phase, function, end-user, technique each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 4 regional and 20 key national markets – See forecasts for the Drug Discovery Informatics Market, 2021 to 2031 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the Drug Discovery Informatics Market, 2021 to 2031 Market.
Read the full report: https://www.reportlinker.com/p06179170/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting